South Korea · Delayed Price · Currency is KRW Narae Nanotech Statistics
Total Valuation
Narae Nanotech has a market cap or net worth of KRW 54.69 billion. The enterprise value is 114.63 billion.
| Market Cap | 54.69B |
| Enterprise Value | 114.63B |
Important Dates
The last earnings date was Friday, February 13, 2026.
| Earnings Date | Feb 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Narae Nanotech has 11.06 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 11.06M |
| Shares Outstanding | 11.06M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 48.69% |
| Owned by Institutions (%) | n/a |
| Float | 5.64M |
Valuation Ratios
The trailing PE ratio is 1.37.
| PE Ratio | 1.37 |
| Forward PE | n/a |
| PS Ratio | 1.00 |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | 4.05 |
| P/OCF Ratio | 3.99 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2.87 |
| EV / Sales | 2.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 8.49 |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.65 |
| Quick Ratio | 1.32 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | n/a |
| Debt / FCF | 4.67 |
| Interest Coverage | -2.99 |
Financial Efficiency
Return on equity (ROE) is 41.46% and return on invested capital (ROIC) is -4.82%.
| Return on Equity (ROE) | 41.46% |
| Return on Assets (ROA) | -3.02% |
| Return on Invested Capital (ROIC) | -4.82% |
| Return on Capital Employed (ROCE) | -7.54% |
| Weighted Average Cost of Capital (WACC) | 6.32% |
| Revenue Per Employee | 360.91M |
| Profits Per Employee | 264.64M |
| Employee Count | 151 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, Narae Nanotech has paid 10.15 billion in taxes.
| Income Tax | 10.15B |
| Effective Tax Rate | 20.25% |
Stock Price Statistics
The stock price has increased by +59.00% in the last 52 weeks. The beta is 0.90, so Narae Nanotech's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +59.00% |
| 50-Day Moving Average | 4,485.00 |
| 200-Day Moving Average | 3,637.55 |
| Relative Strength Index (RSI) | 61.18 |
| Average Volume (20 Days) | 25,350 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Narae Nanotech had revenue of KRW 54.50 billion and earned 39.96 billion in profits. Earnings per share was 3,613.00.
| Revenue | 54.50B |
| Gross Profit | 4.86B |
| Operating Income | -9.00B |
| Pretax Income | 50.11B |
| Net Income | 39.96B |
| EBITDA | -3.79B |
| EBIT | -9.00B |
| Earnings Per Share (EPS) | 3,613.00 |
Balance Sheet
The company has 3.05 billion in cash and 62.99 billion in debt, with a net cash position of -59.94 billion or -5,420.00 per share.
| Cash & Cash Equivalents | 3.05B |
| Total Debt | 62.99B |
| Net Cash | -59.94B |
| Net Cash Per Share | -5,420.00 |
| Equity (Book Value) | 116.35B |
| Book Value Per Share | 10,516.61 |
| Working Capital | 51.23B |
Cash Flow
In the last 12 months, operating cash flow was 13.70 billion and capital expenditures -193.43 million, giving a free cash flow of 13.50 billion.
| Operating Cash Flow | 13.70B |
| Capital Expenditures | -193.43M |
| Depreciation & Amortization | 5.21B |
| Net Borrowing | -17.04B |
| Free Cash Flow | 13.50B |
| FCF Per Share | 1,220.96 |
Margins
Gross margin is 8.92%, with operating and profit margins of -16.52% and 73.33%.
| Gross Margin | 8.92% |
| Operating Margin | -16.52% |
| Pretax Margin | 91.95% |
| Profit Margin | 73.33% |
| EBITDA Margin | -6.95% |
| EBIT Margin | -16.52% |
| FCF Margin | 24.78% |
Dividends & Yields
Narae Nanotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | -0.01% |
| Earnings Yield | 73.07% |
| FCF Yield | 24.69% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Narae Nanotech has an Altman Z-Score of 1.1 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.1 |
| Piotroski F-Score | 6 |